NEVANAC

Product NDC: 0078-0778
11-digit product format: 000780778
Labeler code: 0078
Product ID: 0078-0778_a2909252-c5f1-421f-9073-b7be90b45b51
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: nepafenac
Dosage form: SUSPENSION/ DROPS
Route: OPHTHALMIC
Labeler: Novartis Pharmaceuticals Corporation
Application: NDA021862
Marketing category: NDA
Marketing start: 2005-09-06
Marketing end: 0000-00-00
Substance: NEPAFENAC
Active strength: 1 mg/mL
Pharmacologic classes: Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	0078-0778		I	Inactivated by FDA		2026-08-03
excluded package	package	0078-0778	0078-0778-03	I	Inactivated by FDA		2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 18 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0078-0778-03	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0078-0778-03	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0078-0778-03	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0078-0778-03	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0078-0778-03	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0078-0778-03	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0078-0778-03	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0078-0778-03	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0078-0778-03	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N021862-001	NEVANAC	NEPAFENAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC		RLD, RS	2005-08-19

Orange Book patents#

Current patent rows page 1 of 1 · 1 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N021862-001	7834059	2027-01-31	U-1095		2010-11-30

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N021862-001	NEVANAC	0.1%	SUSPENSION/DROPS / OPHTHALMIC	RLD, RS	2005-08-19	`cb3db0bc1861…`

Observed Orange Book patent history#

Patent history page 1 of 3 · 119 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021862-001	7834059	2027-01-31	U-1095		2010-11-30	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021862-001	8071648	2025-12-02		Drug product	2011-12-16	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021862-001	8324281	2025-12-02		Drug product	2012-12-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021862-001	7834059	2027-01-31	U-1095		2010-11-30	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021862-001	8071648	2025-12-02		Drug product	2011-12-16	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021862-001	8324281	2025-12-02		Drug product	2012-12-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021862-001	7834059	2027-01-31	U-1095		2010-11-30	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021862-001	8071648	2025-12-02		Drug product	2011-12-16	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021862-001	8324281	2025-12-02		Drug product	2012-12-17	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021862-001	7834059	2027-01-31	U-1095		2010-11-30	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021862-001	8071648	2025-12-02		Drug product	2011-12-16	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021862-001	8324281	2025-12-02		Drug product	2012-12-17	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021862-001	7834059	2027-01-31	U-1095		2010-11-30	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021862-001	8071648	2025-12-02		Drug product	2011-12-16	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021862-001	8324281	2025-12-02		Drug product	2012-12-17	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021862-001	7834059	2027-01-31	U-1095		2010-11-30	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021862-001	8071648	2025-12-02		Drug product	2011-12-16	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021862-001	8324281	2025-12-02		Drug product	2012-12-17	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021862-001	7834059	2027-01-31	U-1095		2010-11-30	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021862-001	8071648	2025-12-02		Drug product	2011-12-16	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021862-001	8324281	2025-12-02		Drug product	2012-12-17	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021862-001	7834059	2027-01-31	U-1095		2010-11-30	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021862-001	8071648	2025-12-02		Drug product	2011-12-16	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021862-001	8324281	2025-12-02		Drug product	2012-12-17	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021862-001	7834059	2027-01-31	U-1095		2010-11-30	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021862-001	8071648	2025-12-02		Drug product	2011-12-16	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021862-001	8324281	2025-12-02		Drug product	2012-12-17	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021862-001	7834059	2027-01-31	U-1095		2010-11-30	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021862-001	8071648	2025-12-02		Drug product	2011-12-16	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021862-001	8324281	2025-12-02		Drug product	2012-12-17	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021862-001	7834059	2027-01-31	U-1095		2010-11-30	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021862-001	8071648	2025-12-02		Drug product	2011-12-16	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021862-001	8324281	2025-12-02		Drug product	2012-12-17	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021862-001	7834059	2027-01-31	U-1095		2010-11-30	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021862-001	8071648	2025-12-02		Drug product	2011-12-16	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021862-001	8324281	2025-12-02		Drug product	2012-12-17	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021862-001	7834059	2027-01-31	U-1095		2010-11-30	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021862-001	8071648	2025-12-02		Drug product	2011-12-16	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N021862-001	8324281	2025-12-02		Drug product	2012-12-17	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N021862-001	7834059	2027-01-31	U-1095		2010-11-30	`8072bd15b7f6…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
e884a219-2715-9672-1489-3e3d6a8897e6	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
0078-0778-03	2025-01-30	C162847	48780-1	2cef2736-6612-d83d-e063-dadaa90ab31f	These highlights do not include all the information needed to use NEVANAC safely and effectively. See full prescribing information for NEVANAC. NEVANAC ® (nepafenac ophthalmic suspension) 0.1%, for topical ophthalmic use Initial U.S. Approval: 2005

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0078-0778-03	NEVANAC	3 mL in 1 BOTTLE	SUSPENSION/ DROPS	3		2

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0078-0778-03	ML - Milliliter	0078-0778	64e45c5f-0c08-430c-9d3d-78c1390b78f1	1	2023-02-06

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0078-0778	NEVANAC (NEPAFENAC) SUSPENSION/ DROPS [NOVARTIS PHARMACEUTICALS CORPORATION]	2	Legacy NDC, 1 package rows	20230420_a2909252-c5f1-421f-9073-b7be90b45b51.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
NEVANAC	NEPAFENAC	Harrow Eye, LLC	11b9a0cf-2a70-17ef-e063-6394a90a5d9e	2024-11-05	Warnings, Adverse reactions	Exact identifier application applno (NDA): 021862 application number: NDA021862

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
0J9L7J6V8C	NEPAFENAC	78281-72-8	NEPAFENAC

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
578044	nepafenac 0.1 % Ophthalmic Suspension	PSN	a2909252-c5f1-421f-9073-b7be90b45b51	2
603978	Nevanac 0.1 % Ophthalmic Suspension	PSN	a2909252-c5f1-421f-9073-b7be90b45b51	2
603978	nepafenac 1 MG/ML Ophthalmic Suspension [Nevanac]	SBD	a2909252-c5f1-421f-9073-b7be90b45b51	2
578044	nepafenac 1 MG/ML Ophthalmic Suspension	SCD	a2909252-c5f1-421f-9073-b7be90b45b51	2
578044	nepafenac 0.1 % Ophthalmic Suspension	SY	a2909252-c5f1-421f-9073-b7be90b45b51	2
603978	Nevanac 0.1 % Ophthalmic Suspension	SY	a2909252-c5f1-421f-9073-b7be90b45b51	2
603978	Nevanac 1 MG/ML Ophthalmic Suspension	SY	a2909252-c5f1-421f-9073-b7be90b45b51	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0078-0778-03	00078077803	3 mL in 1 BOTTLE (0078-0778-03)	3 ml	2022-07-05	0000-00-00	No	No	Current